Journal Article (Letter) DZNE-2025-01078

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Springer International Publishing Cham

The journal of prevention of Alzheimer's disease 12(8), 100259 () [10.1016/j.tjpad.2025.100259]

This record in other databases:    

Please use a persistent id in citations: doi:

Classification:

Contributing Institute(s):
  1. Clinical Alzheimer’s Disease Research (AG Jessen)
  2. Clinical Research (Munich) (Clinical Research (Munich))
  3. Clinical Neurophysiology and Memory (AG Düzel)
  4. Vascular Cognitive Impairment & Post-Stroke Dementia (AG Dichgans)
  5. Translational Dementia Research (Bonn) (AG Schneider)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > M DZNE > M DZNE-Clinical Research (Munich)
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > M DZNE > M DZNE-AG Dichgans
Full Text Collection
Public records
Publications Database

 Record created 2025-09-05, last modified 2025-09-28


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)